Efficacy and Safety of Fesoterodine for Overactive Bladder in a Double-Blind, Head-to-Head Comparison Trial With Tolterodine ER and Placebo

Herschorn S1, Swift S2, Guan Z3, Carlsson M3, Brodsky M3, Gong J3

Abstract Category

Pharmacology: Clinical

Abstract 710
Read by Title
Scientific Non Discussion Abstract Session 34
1. University of Toronto, Toronto, ON, Canada, 2. Medical University of South Carolina, Charleston, SC, USA, 3. Pfizer Inc, New York, NY, USA